[Radiation-protective effectiveness of MIGI-K preparation in irradiation of animals with medium-lethal and sublethal doses of x-ray and gamma irradiation].
Mazhul'
V M
VM
Parkhomenko
I M
IM
Volykhina
V E
VE
Kudriashov
Iu B
IuB
Goncharenko
E N
EN
Gul'ko
V V
VV
Rolevich
I V
IV
Gatsko
G G
GG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants; D049872:Bivalvia; D005720:Gamma Rays; D008055:Lipids / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D011492:Protein Hydrolysates; D011829:Radiation Dosage; D011833:Radiation Injuries, Experimental / Q000097:blood / Q000517:prevention & control; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014965:X-Rays
D000276:Adjuvants, Immunologic; D000975:Antioxidants; D008055:Lipids; D011492:Protein Hydrolysates; D011837:Radiation-Protective Agents; D008315:Malondialdehyde; C073589:MIGI-K